Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Gastrointestinal 1

Conditions

Fatigue 16Neoplasms 8Depression 5Brain Neoplasms 5Prostatic Neoplasms 4Sleep Wake Disorders 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Central Nervous System Neoplasms 2Breast Neoplasms 2Asthenia 2Recurrence 1Pain 1Oligodendroglioma 1Neurotoxicity Syndromes 1Neurofibromatosis 1 1Neuroectodermal Tumors, Primitive 1Neoplasm Metastasis 1Multiple Endocrine Neoplasia Type 1 1Mental Disorders 1Meningioma 1Hematologic Neoplasms 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Gastrointestinal Neoplasms 1Ependymoma 1Cognitive Dysfunction 1Caregiver Burden 1Astrocytoma 1

Interventions

Trastuzumab 594Paclitaxel 561Cyclophosphamide 545Docetaxel 478Capecitabine 387Letrozole 350Fulvestrant 310Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 175Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × Methylphenidate × Clear all
NCT02970500 2023-03-23

CogMet

CHU de Quebec-Universite Laval

Phase 2 Terminated
20 enrolled
Breast

Breast Neoplasms, Cognitive Dysfunction

NCT00516269 2018-01-03

Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients

M.D. Anderson Cancer Center

Phase 3 Terminated
42 enrolled 8 charts
BreastGastrointestinal

Breast Neoplasms, Fatigue, Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡